Study Evaluating Alectinib Pharmacokinetics in the Hispanic Population With Advanced ALK-Rearranged Non-small-Cell Lung Cancer

被引：0
|
作者：
Arrieta, Oscar [1 ]
Lara-Mejia, Luis [1 ]
Garcia Lopez, Patricia [2 ]
Hernandez-Pedro, Norma [3 ,4 ]
Cruz-Rico, Graciela [1 ]
Heredia, David [1 ]
Sanchez-Reyes, Roberto [1 ]
Infante-Gonzalez, Cesar [1 ]
Martinez Perez, Aida
Matias-Cruz, Venecia [1 ]
Lopez Samchez, Denise [1 ]
Cardona, Andres [5 ]
机构：
[1] Inst Nacl Cancerol, Thorac Oncol Dept, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Inst Nacl Cancerol, Lab Farmacol, Subdirecc Invest Basica, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Thorac Oncol Unit, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol, Lab Personalized Med, Mexico City, DF, Mexico
[5] Clin Country, Clin & Traslat Oncol Grp, Bogota, Colombia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.01
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [21] ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism
    Zer, Alona
    Moskovitz, Mor
    Hwang, David M.
    Hershko-Klement, Anat
    Fridel, Ludmila
    Korpanty, Grzegorz J.
    Dudnik, Elizabeth
    Peled, Nir
    Shochat, Tzippy
    Leighl, Natasha B.
    Liu, Geoffrey
    Feld, Ronald
    Burkes, Ronald
    Wollner, Mira
    Tsao, Ming-Sound
    Shepherd, Frances A.
    CLINICAL LUNG CANCER, 2017, 18 (02) : 156 - 161
  • [22] Updated Survival Data in Advanced ALK-rearranged Non-small Cell Lung Cancer Treated with Alectinib and Bevacizumab in the ALEK-B Study
    Arrieta, O.
    Lara-Mejia, L.
    Cabrera-Miranda, L.
    Heredia, D.
    Ramos-Ramirez, M.
    Caballe, E.
    Davila-Dupont, D.
    Cardona, A. F. F.
    Cruz-Rico, G.
    Remon, J.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S355 - S356
  • [23] Efficacy and safety study with alectinib in advanced ALK-positive non-small-cell lung cancer
    Fernandez Madrigal, Laura
    Garcia Samblas, Victoria
    Amor Urbano, Maria
    Inoriza, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Dramatic response to alectinib in a patient with ALK-rearranged squamous cell lung cancer
    Shiihara, Jun
    Ohyanagi, Fumiyoshi
    Amari, Hikari
    Toda, Minemichi
    Tahara, Hiroki
    Yuzawa, Motoi
    Maeda, Yuki
    Nomura, Motoko
    Mizushina, Yoshiko
    Nagai, Yoshiaki
    Ohta, Hiromitsu
    Yamaguchi, Yasuhiro
    THORACIC CANCER, 2021, 12 (17) : 2420 - 2423
  • [25] Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China
    Puyuan Xing
    Shouzheng Wang
    Qiang Wang
    Di Ma
    Xuezhi Hao
    Mengzhao Wang
    Yan Wang
    Li Shan
    Tao Xin
    Li Liang
    Hongge Liang
    Yang Du
    Zhaohui Zhang
    Junling Li
    Targeted Oncology, 2019, 14 : 325 - 333
  • [26] Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China
    Xing, Puyuan
    Wang, Shouzheng
    Wang, Qiang
    Ma, Di
    Hao, Xuezhi
    Wang, Mengzhao
    Wang, Yan
    Shan, Li
    Xin, Tao
    Liang, Li
    Liang, Hongge
    Du, Yang
    Zhang, Zhaohui
    Li, Junling
    TARGETED ONCOLOGY, 2019, 14 (03) : 325 - 333
  • [27] Clinical Efficacy of Alectinib in Patients with ALK-Rearranged Non-small Cell Lung Cancer After Ceritinib Failure
    Oya, Yuko
    Yoshida, Tatsuya
    Kuroda, Hiroaki
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Hida, Toyoaki
    Yatabe, Yasushi
    ANTICANCER RESEARCH, 2017, 37 (11) : 6477 - 6480
  • [28] Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study
    Dagogo-Jack, Ibiayi
    Cooper, Alissa J.
    Johnson, Bruce E.
    Gainor, Justin F.
    Lin, Jessica J.
    Sequist, Lecia V.
    Piotrowska, Zofia
    Digumarthy, Subba R.
    Mino-Kenudson, Mari
    Muzikansky, Alona
    Shaw, Alice T.
    LUNG CANCER, 2025, 199
  • [29] Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it
    M. Drizou
    E. A. Kotteas
    N. Syrigos
    Clinical and Translational Oncology, 2017, 19 : 658 - 666
  • [30] Molecular imaging as a predictive biomarker response to Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Medina-Ornelas, S.
    Garcia-Perez, F.
    Arrieta-Rodriguez, O.
    Barron-Barron, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S568 - S568
12345